NCT02659241 2026-04-15
Adavosertib Before Surgery in Treating Patients With Advanced High Grade Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Active not recruiting
Clinical Trials
108 trialsNCT05047913 2026-04-15
Comprehensive Evaluation of Tumor Oxygenation, Metabolism and Blood Supply of High Grade Glioma and Cervical Cancers Using Dynamic FAZA PET and Multiparametric MR
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Active not recruiting
NCT05053750 2026-04-15
TAME: A Pilot Study of Weekly Paclitaxel, Bevacizumab, and Tumor Associated Macrophage Targeted Therapy (Zoledronic Acid) in Women With Recurrent, Platinum-resistant, Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Active not recruiting
NCT04494113 2026-04-13
Testing the Response to the Anti-cancer Drug, Triapine, in Uterine Cancers Using Markers From the Tissue at the Time of Hysterectomy
National Cancer Institute (NCI)
Phase EARLY_PHASE1 Active not recruiting
NCT06751589 2026-04-13
A Study of a Weight Loss Intervention in People With Endometrial Cancer
Memorial Sloan Kettering Cancer Center
Phase EARLY_PHASE1 Recruiting
NCT03832985 2026-04-09
Pediatric Reporting of Adult-Onset Genomic Results
Geisinger Clinic
Phase EARLY_PHASE1 Completed
NCT05080946 2026-04-01
Using Aspirin to Improve Immunological Features of Ovarian Tumors
H. Lee Moffitt Cancer Center and Research Institute
Phase EARLY_PHASE1 Recruiting
NCT07429071 2026-03-04
Effectiveness of a Vaginal Gel on CIN1/2 Regression and HPV Clearance.
University of Aarhus
Phase EARLY_PHASE1 Not yet recruiting
NCT06511037 2026-02-27
PhI Pilot Study Pafolacianine Inject for Intraoperative Imaging on Outcomes of GI Cancer Peritoneal Carcinomatosis
University of California, Irvine
Phase EARLY_PHASE1 Recruiting
NCT03943173 2026-02-25
Olaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cancer Before Surgery
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Active not recruiting
NCT06305962 2026-02-19
177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors
Radiopharm Theranostics, Ltd
Phase EARLY_PHASE1 Recruiting
NCT07420010 2026-02-19
An Open-label, Single-arm Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of KT032 Cell Injection in Patients With Mesothelin-positive Advanced Solid Tumors.
Zhejiang University
Phase EARLY_PHASE1 Not yet recruiting
NCT03771651 2026-02-17
Short Term Aspirin on the Biologic and Immunologic Changes of the Fallopian Tube
University of Oklahoma
Phase EARLY_PHASE1 Active not recruiting
NCT07144826 2026-02-13
Effects of a Probiotic Intervention on the Gut and Vaginal Microbiome in Patients With Advanced or Recurrent Ovarian Cancer Undergoing Treatment With Platinum Chemotherapy
Ohio State University Comprehensive Cancer Center
Phase EARLY_PHASE1 Recruiting
NCT05415709 2026-02-11
Hyperthermic Intraperitoneal Chemotherapy With Cisplatin During Surgery or Cisplatin Before Surgery for the Treatment of Stage III or IV Ovarian, Fallopian Tube or Peritoneal Cancer
Ohio State University Comprehensive Cancer Center
Phase EARLY_PHASE1 Recruiting
NCT04457089 2026-02-04
Statin Therapy to Reduce Progression in Women With Platinum Sensitive Ovarian Cancer
Cedars-Sinai Medical Center
Phase EARLY_PHASE1 Completed
NCT05691010 2026-02-04
A Study of Short-Course Radiation Therapy With Chemotherapy in People With Endometrial Cancer
Memorial Sloan Kettering Cancer Center
Phase EARLY_PHASE1 Recruiting
NCT02554344 2026-01-30
Effect of Curcumin in Treatment of Squamous Cervical Intraepithelial Neoplasias (CINs)
Baylor Research Institute
Phase EARLY_PHASE1 Withdrawn
NCT06639191 2026-01-30
AKIR001
Karolinska University Hospital
Phase EARLY_PHASE1 Recruiting
NCT07065552 2026-01-28
Tirzepatide in Obesity-Driven Endometrial Cancer
UNC Lineberger Comprehensive Cancer Center
Phase EARLY_PHASE1 Not yet recruiting
NCT07316361 2026-01-07
GYNORYLAQâ„¢
Biogenea Pharmaceuticals Ltd.
Phase EARLY_PHASE1 Enrolling by invitation
NCT04051502 2025-12-17
ICG-Enabled Mapping of Ovarian Sentinel Lymph Nodes: A Feasibility Study
Memorial Sloan Kettering Cancer Center
Phase EARLY_PHASE1 Completed
NCT07278986 2025-12-12
CYTALUX ISS
Abramson Cancer Center at Penn Medicine
Phase EARLY_PHASE1 Recruiting
NCT04219904 2025-11-18
PET/MRI Scan for the Evaluation of Resectable Stage IA1-IB3 Cervical Cancer
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Active not recruiting
NCT02111941 2025-10-31
Vaccine Therapy for Patients With Stage IIIC-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer
Mayo Clinic
Phase EARLY_PHASE1 Completed
NCT04049227 2025-10-20
Abemaciclib and Letrozole in Treating Patients With Endometrial Cancer
Northwestern University
Phase EARLY_PHASE1 Completed
NCT07106814 2025-09-15
Safety and Efficacy of Metabolically Armed Tumor-lnfiltrating Lymphocytes (Meta10-TIL) for the Treatment of Advanced Solid Tumors
Anhui Provincial Hospital
Phase EARLY_PHASE1 Recruiting
NCT04630353 2025-09-12
A Study HB-201 in Patients With Newly Diagnosed HPV16+ Oropharynx or Locally Advanced Cervical Cancer
Hookipa Biotech GmbH
Phase EARLY_PHASE1 Terminated
NCT05105087 2025-08-22
Gynecological Sentinel Lymph Nodes CEUS
Thomas Jefferson University
Phase EARLY_PHASE1 Completed
NCT04147494 2025-08-12
Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues
Jonsson Comprehensive Cancer Center
Phase EARLY_PHASE1 Active not recruiting
NCT05320757 2025-06-11
Effects of PARP Inhibitor on Tumor Microenvironment in High-risk Endometrial Cancer Patients
The University of Hong Kong
Phase EARLY_PHASE1 Completed
NCT03196180 2025-04-08
Topical Fluorouracil and Imiquimod in Treating Patients With High-Grade Cervical Intraepithelial Neoplasia
National Cancer Institute (NCI)
Phase EARLY_PHASE1 Completed
NCT06887673 2025-03-20
Lipid Mediators & Cancer: Montelukast, SPM, and Almonds
University of South Florida
Phase EARLY_PHASE1 Not yet recruiting
NCT04213794 2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1 Terminated
NCT04906382 2025-02-13
Tislelizumab for the Treatment of Recurrent Mismatch Repair Deficient Endometrial Cancer
Ohio State University Comprehensive Cancer Center
Phase EARLY_PHASE1 Terminated
NCT06825455 2025-02-13
Allogeneic B7H3 CAR-γδT Cell Therapy for Advanced Solid Tumors
Peking University
Phase EARLY_PHASE1 Not yet recruiting
NCT05289648 2024-12-19
NIREC
Sir Mortimer B. Davis - Jewish General Hospital
Phase EARLY_PHASE1 Withdrawn
NCT02042430 2024-12-13
Epacadostat Before Surgery in Treating Patients With Newly Diagnosed Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
National Cancer Institute (NCI)
Phase EARLY_PHASE1 Completed
NCT03514121 2024-11-22
FPA150-001
Five Prime Therapeutics, Inc.
Phase EARLY_PHASE1 Terminated
NCT03378297 2024-10-30
IMPACT
Haukeland University Hospital
Phase EARLY_PHASE1 Completed
NCT06660511 2024-10-28
Exploratory Study on the Safety and Efficacy of Disitamab Vedotin in Combination with Anlotinib Hydrochloride for the Treatment of HER-2-expressing Recurrent Platinum-resistant Ovarian Cancer.
Second Xiangya Hospital of Central South University
Phase EARLY_PHASE1 Recruiting
NCT04067960 2024-08-14
Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV Cancer
Mayo Clinic
Phase EARLY_PHASE1 Completed
NCT05856643 2024-08-13
Single-arm, Open-label Clinical Study of SZ011 in the Treatment of Ovarian Epithelial Carcinoma
Shantou University Medical College
Phase EARLY_PHASE1 Recruiting
NCT04199754 2024-05-31
IV Contrast-Enhanced Cone Beam Computed Tomography (CBCT) in Radiotherapy
Columbia University
Phase EARLY_PHASE1 Terminated
NCT06284226 2024-04-16
CCT-ANK-11
Beijing Kejing Biotechnology Co., Ltd.
Phase EARLY_PHASE1 Withdrawn
NCT02728830 2024-02-21
A Study of Pembrolizumab on the Tumoral Immunoprofile of Gynecologic Cancers
Duke University
Phase EARLY_PHASE1 Completed
NCT05238831 2024-01-23
SMMART Adaptive Clinical Treatment (ACT) Trial
OHSU Knight Cancer Institute
Phase EARLY_PHASE1 Withdrawn
NCT05465590 2023-12-21
A Phase 1 Study to Evaluate Paclitaxel Conjugated CXC Receptor 4 Antagonist (MB1707) in Patients With Advanced Cancer
Mainline Biosciences, Inc.
Phase EARLY_PHASE1 Withdrawn
NCT03694834 2023-11-28
Window of Opportunity Pilot Study of Pembrolizumab in Obesity-driven Endometrial Cancer
UNC Lineberger Comprehensive Cancer Center
Phase EARLY_PHASE1 Terminated
NCT05886075 2023-06-02
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors
Shanghai Yunying Medical Technology
Phase EARLY_PHASE1 Unknown